Abstract:Chemotherapy-Related Cognitive Impairments (CRCIs) encompass cognitive deficits in memory, attention, and executive function that arise during and following chemotherapy. CRCI symptoms are predominantly reported by female cancer patients, but also occur in males. These impairments may involve reduced estradiol levels, which then increases vulnerability to the impact of tumors and chemotherapy on cognition. This study utilized the MMTV-PyVT mouse model of breast cancer to test the hypothesis that impaired ovarian function and associated estradiol levels play a critical role in CRCI susceptibility. Mice were either ovariectomized (OVX) or underwent sham surgery. The the OVX group then received supplemental estradiol (E2) ad libitum in the drinking water to maintain physiological hormone levels. After tumor development, mice were trained in the Morris water maze (MWM) to assess spatial memory, and subsequently, they received weekly injections of either saline or a combination of cyclophosphamide (CYP; 66.7mg/kg, i.v.) and doxorubicin (DOX; 6.7mg/kg, i.v.) for four weeks. Spatial memory was reassessed 10 days, and then 35 days, after the final injections. Results demonstrated a significant disruption of normal ovarian cycling in sham operated mice treated with CYP+DOX, as well as significant spatial memory impairments when compared to OVX mice supplemented with E2 This study suggests that chemotherapy-induced ovarian damage and the consequent drop in circulating estrogens significantly contribute to vulnerability to CRCIs, underscoring the importance of estradiol in mitigating CRCI risks.Significance Statement This study demonstrates that impairment of ovarian function in sham mice contributes to the manifestation of CRCIs. The observation that cognitive impairments were not present in E2 supplemented OVX animals suggests that disruptions of circulating E2 by chemotherapy mediates vulnerability to CRCIs. Unfortunately, OVX mice receiving E2 supplementation exhibited increased tumor volume in comparison to sham mice receiving tap water, suggesting that maintaining E2 can interfere with treatment. Therefore, E2 supplementation is unlikely to be an acceptable therapeutic intervention for CRCIs in cancers with tumors that express estrogen receptors. However, targeting mechanisms downstream of E2, such as high affinity choline uptake, may be effective interventions for CRCIs.

Ovariectomy and Estradiol Supplementation Prevents Cyclophosphamide and Doxorubicin Induced Spatial Memory Impairment in Tumor Bearing MMTV-PyVT Mice